Both lymphoblastic lymphomas can progress further to acute lymphoblastic leukemia, and both are currently considered to be different stages of the same disease, so the current treatment regimen for lymphoblastic lymphomas is that of acute lymphoblastic leukemia. These include induction remission chemotherapy, intensive consolidation chemotherapy after remission, maintenance therapy, and prophylaxis of central nervous system leukemia. Lymphoblast lymphoma often invades the center, so it is important to prevent central invasion.
In children with lymphoblastic lymphoma, the long-term survival rate is more than 85% after regular treatment, and early stage patients have a better prognosis, so they should be treated aggressively.